IDiyas

For the Inventor, By the Inventor

Martinez, CA, United States of America

Exthera Medical Corporation


USPTO Granted Patents = 22



Trademarks = 7

Forward Citations = 212

Loading Chart...
Loading Chart...

35 inventors (with patents filed for the assignee):

goldMedal Robert S Ward (17 out of 45 patents)

silverMedal Keith R McCrea (16 out of 23 patents)

bronzeMedal Olle Larm (13 out of 25 patents)

4.  Lars Adolfsson (7 out of 8 patents)

5.  Tomas Bergstrom (5 out of 5 patents)

6.  Jonas Axelsson (2 out of 2 patents)

7.  Tomas Bergström (2 out of 4 patents)

8.  George Pitarra, Jr (1 out of 1 patent)

9.  Keith McCrae (1 out of 1 patent)

10.  Lakhmir (Mink) Chawla (1 out of 1 patent)

11.  Keith McCREA (0 patent)

12.  Keith R Mccrea (0 patent)

13.  Lars Adolfsson (0 patent)

14.  Olle Larm (0 patent)

15.  Keith Mccrea (0 patent)


22 patents:

1. 12090261 - Method for modulating endothelial glycocalyx structure (2024-09-17),
2. 11911551 - Method for treating drug intoxication (2024-02-27),
3. 11844895 - Method for removing bacteria from blood using high flow rate (2023-12-19),
4. 11306346 - Methods for diagnosing infectious diseases using adsorption media (2022-04-19),
5. 11266772 - Use of heparin and carbohydrates to treat cancer (2022-03-08),
6. 11123466 - Methods for removing cytokines from blood with surface immobilized polysaccharides (2021-09-21),
7. 11065378 - Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood (2021-07-20),
8. 10857283 - Wearable hemoperfusion device (2020-12-08),
9. 10786615 - Method for treating drug intoxication (2020-09-29),
10. 10688239 - Method for extracorporeal removal of a pathogenic microbe, an inflammatory cell or an inflammatory protein from blood (2020-06-23),
11. 10639413 - Blood filtration system containing mannose coated substrate (2020-05-05),
12. 10537280 - Device and method for removal of blood-borne pathogens, toxins and inflammatory cytokines (2020-01-21),
13. 10487350 - Methods for diagnosing infectious diseases using adsorption media (2019-11-26),
14. 10457974 - Methods for diagnosing infectious diseases using adsorption media (2019-10-29),
15. 10188783 - Method for extracorporeal removal of pathogenic microbe, an inflammatory cell or an inflammatory protein from blood (2019-01-29),
ExThera Medical Corporation is a medical technology company focused on the development and commercialization of innovative therapies for the treatment of bloodstream infections. Their flagship product, Seraph® 100 Microbind® Affinity Blood Filter, is an extracorporeal device designed to rapidly remove pathogens from the bloodstream, providing a novel treatment option for patients with severe infections. ExThera Medical Corporation is committed to improving patient outcomes and revolutionizing infection management.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

22 Patents

#2 in Martinez, CA

#3,449 in California

#14,497 in US

#27,846 in the World

...
Martinez, CA, United States of America

Exthera Medical Corporation

Forward Citations = 212

35 inventors:

goldMedal Robert S Ward (17 out of 45 patents)

silverMedal Keith R McCrea (16 out of 23 patents)

bronzeMedal Olle Larm (13 out of 25 patents)

4.  Lars Adolfsson (7 out of 8 patents)

5.  Tomas Bergstrom (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com
Loading…